CDK5 and cancer: Moreover, we observed the underappreciated function of CDK5 in enhancing TILs infiltration, indicating a narrow association between CSCs and T‐cell infiltration in tumor tissues.[47] In conclusion, these results bring us new hope that targeting CDK5 may sensitize TNBC and other immunologically “cold” cancer types to immunotherapy.